Astraea in the Spotlight
Novel drug candidate with a first-in-class mechanism for smoking cessation & abstinence, advancing into clinical development
Dr. Nurulain T. Zaveri, PhD, FAAPS, is the first recipient of inaugural 2020 Alice E. Till Recognition for Advancement of Women in Pharmaceutical Sciences, from the American Association of Pharmaceutical Sciences (AAPS).
Dr. Zaveri is a Fellow of the AAPS, and a founding leader for the Women in Pharmaceutical Sciences community at AAPS.
"AT-121, a small molecule agonist of two opioid receptors, mediates analgesia without opioid-associated side effects in nonhuman primates" - Science Translational Medicine
A Promising Alternative to Opioid Pain Medications
Dr. Nurulain T. Zaveri, PhD
President and Chief Scientific Officer